Neurology Minute

Dr. Nicholas Johnson discusses myotonic muscular dystrophies in the fourth part of this four-part series. To learn more, read the article "Myotonic Muscular Dystrophies" by Dr. Johnson in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum, which is open to all until March 1, 2020, at continpub.com/MuscDys.  

Dr. Nicholas Johnson discusses myotonic muscular dystrophies in the third part of this four-part series. To learn more, read the article "Myotonic Muscular Dystrophies" by Dr. Johnson in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum, which is open to all until March 1, 2020, at continpub.com/MuscDys.  

Dr. Daniel Hartung discusses the take-home message from his paper, "Qualitative study on the price of drugs for multiple sclerosis".

Dr. Stacey Clardy discusses features and diagnosis of relapsing polychondritis.

Dr. Stacey Clardy talks about CTLA4 deficiency and relevance to neurology.

Dr. Nicholas Johnson discusses myotonic muscular dystrophies in the second part of this four-part series. To learn more, read the article "Myotonic Muscular Dystrophies" by Dr. Johnson in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum, which is open to all until March 1, 2020, at continpub.com/MuscDys.  

Dr. Charles Bernick discusses the main points from his paper on repetitive head impacts in professional fighters and brain volume. 

Dr. Amy Gelfand discusses the main points from her interview on infant colic and episodic syndromes and their association with migraine.

Dr. Stacey Clardy discusses GAD65-associated neurologic autoimmunity, including clues for diagnosis. 

Dr. Nicholas Johnson discusses myotonic muscular dystrophies in the first part of a three-part series. To learn more, read the article "Myotonic Muscular Dystrophies" by Dr. Johnson in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum,which is open to all until March 1, 2020 at continpub.com/MuscDys.  

Dr. Dalmau and Dr. Graus discuss the main takeaways on their paper on Hashimoto’s Encephalopathy and whether we should continue to use the term.

Dr. Richard Lipton and Dr. Dawn Buse discuss the main takeaways from their paper on migraine progression in migraine subgroups based on comorbidities.

Dr. Christopher Doughty discusses toxic myopathies in the third part of a three-part series. To learn more, read the article "Toxic Myopathies" by Dr. Doughty in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum. 

Dr. Mary Reilly discusses the main takeaways from her paper on next-generation, sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.

Dr. Brad Klein provides updates for 2020 on evaluation & management (E&M) coding changes. 

Dr. Christopher Doughty discusses toxic myopathies in the second part of a three-part series. To learn more, read the article "Toxic Myopathies" by Dr. Doughty in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum. 

Dr. Megan Seay talks about relative afferent pupillary defects (RAPDs).

Dr. Teshamae Monteith discusses the interaction between the nose and migraine. 

Dr. Megan Seay discusses how to assess patients' eye movements.

Dr. Christopher Doughty discusses toxic myopathies in the first part of a three-part series. To learn more, read the article "Toxic Myopathies" by Dr. Doughty in the December 2019 Muscle and Neuromuscular Junction Disorders issue of Continuum.